We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the full press release to hear more on the partnership, and the three strategic platforms that CSL Behring is currently focusing on.

“This partnership will help us identify and build relationships with potential external collaborators from throughout Europe…” – Dr. Adrian Zuercher, Vice President, Research Europe and Head of Plasma Protein Research, CSL Behring

Read the full press release here.

 

 

Share this article

View all news

Sign up to receive our newsletter in your inbox.